Showing 2,121 - 2,140 results of 41,221 for search '"medical"', query time: 0.11s Refine Results
  1. 2121

    Medical care and initial health status of French children returnees from jihadist group operation areas: A cross-sectional study from 2017 to 2020 in one referral French hospital by J. Goutines, L.L. Pham, N. Lucidarme, C. Briand, A. Malka, C. Baker, M. Veyret-Morau, A. Mapelli, A. Klein, T. Baubet, L. De Pontual

    Published 2025-03-01
    “…Since 2017, a national procedure in France has been designed to coordinate their care, including a systematic pediatric medical assessment. Methods: The aim of this cross-sectional study was to assess the prevalence rate of diseases diagnosed at their arrival in France. …”
    Get full text
    Article
  2. 2122
  3. 2123
  4. 2124

    A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment of type 2 diabetes mellitus by Yan Gong, James Rogers, Christian Friedrich, Sanjay Patel, Alexander Staab, Jorge Luiz Gross, Daniel Polhamus, William Gillespie, Brigitta Ursula Monz, Silke Retlich

    Published 2013-03-01
    “…Comparison of two oral dipeptidyl peptidase (DPP)-4 inhibitors, sitagliptin and linagliptin, for type 2 diabetes mellitus (T2DM) treatment was used as an example.Design Systematic review with MBMA.Data sources MEDLINE, EMBASE, http://www.ClinicalTrials.gov, Cochrane review of DPP-4 inhibitors for T2DM, sitagliptin trials on Food and Drug Administration website to December 2011 and linagliptin data from the manufacturer.Eligibility criteria for selecting studies Double-blind, randomised controlled clinical trials, ≥12 weeks’ duration, that analysed sitagliptin or linagliptin efficacies as changes in glycated haemoglobin (HbA1c) levels, in adults with T2DM and HbA1c >7%, irrespective of background medication.Model development and application A Bayesian model was fitted (Markov Chain Monte Carlo method). …”
    Get full text
    Article
  5. 2125

    Reduction of Lipid-Core Burden Index in Nonculprit Lesions at Follow-Up after ST-Elevation Myocardial Infarction: A Randomized Study of Bioresorbable Vascular Scaffold versus Optimal Medical Therapy by Joelle Kefer, Patrick Chenu, Olivier Gurné, Frederic Maes, Théophile Tamakloé, Christophe Beauloye

    Published 2021-01-01
    “…Of these, 15 were LRPs and were randomly assigned to either the BVS + optimal medical therapy (OMT) arm (group 1; N = 7) or the OMT arm (group 2; N = 8). …”
    Get full text
    Article
  6. 2126
  7. 2127

    Impact of E-Learning, Perception and Attitude among Students and Faculty following the COVID-19 Pandemic by Syed Hamza Zia, Ghina Rizwan, Afifa Ehsan, Zarnab Rizwan, Rabia Masood, Naila Umer

    Published 2023-04-01
    Subjects: “…Coronavirus, Education, E-Learning, Pakistan, Teaching, Undergraduate medical education, Virtual learning experience.…”
    Get full text
    Article
  8. 2128
  9. 2129
  10. 2130
  11. 2131
  12. 2132
  13. 2133
  14. 2134
  15. 2135
  16. 2136
  17. 2137
  18. 2138
  19. 2139
  20. 2140